Welcome to LookChem.com Sign In|Join Free

CAS

  • or

321318-11-0

Post Buying Request

321318-11-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

321318-11-0 Usage

General Description

1-(3,5-difluorophenyl)ethan-1-amine hydrochloride is a chemical compound that consists of a phenyl ring with two fluorine atoms at the 3 and 5 positions, attached to an ethylamine group. It is commonly used as a pharmaceutical intermediate in the synthesis of various medications and drug products. The hydrochloride salt form of this compound increases its solubility in water, making it suitable for use in pharmaceutical formulations. This chemical may possess various pharmacological properties and has potential applications in the development of new drugs. Additionally, it may also be used as a research tool or reagent in chemical and biological studies.

Check Digit Verification of cas no

The CAS Registry Mumber 321318-11-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,1,3,1 and 8 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 321318-11:
(8*3)+(7*2)+(6*1)+(5*3)+(4*1)+(3*8)+(2*1)+(1*1)=90
90 % 10 = 0
So 321318-11-0 is a valid CAS Registry Number.

321318-11-0Downstream Products

321318-11-0Relevant articles and documents

BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF

-

Paragraph 0222-0223, (2019/03/30)

The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.

PYRIMIDINEDIONE COMPOUNDS AGAINST CARDIAC CONDITIONS

-

, (2015/01/07)

Provided are novel pyrimidine dione compounds and pharmaceutically acceptable salts thereof, that are useful for the treatment of hypertrophic cardiomyopathy (HCM) and conditions associated with left ventricular hypertrophy or diastolic dysfunction. The synthesis and characterization of the compounds and pharmaceutically acceptable salts thereof, are described, as well as methods for treating HCM and other forms of heart disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 321318-11-0